EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Randomized Controlled Trial to Evaluate the Effect of Sandhyaadhigatavata Guggulu in Sandhigata Vata w.s.r. to Osteoarthritis of the Knee Joint

Lokeshwari S, Veerakumara K

Journal of Ayurveda and Integrated Medical Sciences · 12.08.2026 · 11 (7) · 29-37

DOI: 10.21760/jaims.11.7.5 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 12.08.2026. Verfasst von Lokeshwari S und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sandhigata Vata, correlating with knee osteoarthritis (OA), is a prevalent degenerative disorder. While classical Ayurvedic formulations like Rasnadi Guggulu and Sandhyaadhigatavata Guggulu are widely used for Vata Vyadhi, comparative clinical evidence remains limited.

Objective

To evaluate and compare the efficacy of Sandhyaadhigatavata Guggulu (trial drug) and Rasnadi Guggulu (control) in managing Sandhigata Vata. Materials and Methods: A randomized, open-label, parallel-group trial included 30 patients with knee OA diagnosed via ACR and classical Ayurvedic criteria. Participants were randomized (1:1) into Group A (Rasnadi Guggulu) and Group B (Sandhyaadhigatavata Guggulu). Both received 500 mg capsules (6 daily) with Ksheera for 14 days, followed by a 28-day follow-up. The primary outcome was the WOMAC index; secondary outcomes included VAS pain, stiffness, crepitus, tenderness, swelling, range of movement, and functional tests.

Results

Both groups demonstrated statistically significant within-group improvements across most parameters (P < 0.05). Group B showed greater percentage improvements in pain (39.2%), stiffness (53.4%), tenderness (45.27%), and WOMAC score (44.47%) compared to Group A. However, intergroup differences lacked statistical significance for most parameters, except for swelling (P = 0.003), which showed significant improvement in Group B. No adverse drug reactions were reported.

Conclusion

Both formulations effectively manage Sandhigata Vata. Sandhyaadhigatavata Guggulu demonstrated comparatively better clinical improvement in most parameters, though statistically significant superiority was only observed in reducing swelling. Trial Registration: CTRI/2024/10/075455.

Zitieren

APA

S, L., & K, V. (2026). A Randomized Controlled Trial to Evaluate the Effect of Sandhyaadhigatavata Guggulu in Sandhigata Vata w.s.r. to Osteoarthritis of the Knee Joint. Journal of Ayurveda and Integrated Medical Sciences, 11(7), 29-37. https://doi.org/10.21760/jaims.11.7.5

Vancouver

S L, K V. A Randomized Controlled Trial to Evaluate the Effect of Sandhyaadhigatavata Guggulu in Sandhigata Vata w.s.r. to Osteoarthritis of the Knee Joint. Journal of Ayurveda and Integrated Medical Sciences. 2026;11(7):29-37. doi:10.21760/jaims.11.7.5

BibTeX
@article{S2026,
  author = {S, Lokeshwari and K, Veerakumara},
  title = {A Randomized Controlled Trial to Evaluate the Effect of Sandhyaadhigatavata Guggulu in Sandhigata Vata w.s.r. to Osteoarthritis of the Knee Joint},
  journal = {Journal of Ayurveda and Integrated Medical Sciences},
  year = {2026},
  volume = {11},
  number = {7},
  pages = {29--37},
  doi = {10.21760/jaims.11.7.5}
}
Kostenlos starten →